NCT01671072View on ClinicalTrials.gov

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

January 31, 2013

Conditions
Degenerative Arthritis
Interventions
BIOLOGICAL

TissueGene-C

TissueGene-C at 1.8 x 10\^7 cells

DRUG

Normal Saline

Sodium chloride 0.9%, 3.5ml

Trial Locations (3)

135-710

Samsung Medical Center, Gangnam-gu

110-744

Seoul National Univ. Hospital, Seoul

138-736

Asan Medical Center, Seoul

Sponsors

Lead Sponsor

Kolon Life Science
All Listed Sponsors
lead

Kolon Life Science

INDUSTRY